Citius Oncology, Inc. (CTOR) — Cash Flow Reinvestment Rate
Citius Oncology, Inc. (CTOR) has a Cash Flow Reinvestment Rate of 0.00x as of September 2024, reinvesting $0.46 (capex $0.46 ) from operating cash flow of $900.29K. Check earnings quality score of Citius Oncology, Inc. to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Citius Oncology, Inc. Cash Flow Reinvestment Rate (2024–2024)
Historical reinvestment intensity for Citius Oncology, Inc. across 1 annual periods. Explore Citius Oncology, Inc. cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Citius Oncology, Inc. (2024–2024)
Year-by-year capital reinvestment analysis for Citius Oncology, Inc.. For live market cap and broader valuation context, see market cap of Citius Oncology, Inc..
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 39.57x | $5.00 Million | $126.35K | $4.00 | — |